We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Beam Triggers ‘Nanodroplets' For Targeted Drug Delivery

By MedImaging International staff writers
Posted on 21 Jun 2024
Print article
Image: Ultrasound beam triggers ‘nanodroplets\' to deliver drugs at exactly the right spot (Photo courtesy of 123RF)
Image: Ultrasound beam triggers ‘nanodroplets\' to deliver drugs at exactly the right spot (Photo courtesy of 123RF)

Traditional methods of drug delivery are often inefficient and imprecise, dispersing medication throughout the body, including in areas where it’s not needed and may even be harmful. Achieving targeted delivery could significantly reduce the necessary dosage and minimize side effects. Scientists have now refined an emerging technique that achieves targeted drug delivery, making it safe and efficient for the first time and setting the stage for potential human trials.

Scientists at the University of Utah (Salt Lake City, UT, USA) have developed a technique that employs ultrasound waves to release drugs from nanocarriers at specific body sites. These nanocarriers are tiny, ranging from 470 to 550 nanometers in diameter, and consist of a hollow polymer shell. The shell’s polymers are designed with two ends: a 'hydrophilic' end that is compatible with water and faces outward, and a 'hydrophobic' end that repels water and faces inward. Enclosed within this shell is a core made up of hydrophobic perfluorocarbons, which are primarily composed of fluorine and carbon, mixed with a hydrophobic drug. This design prevents the cores from coalescing into a single droplet and forms a barrier against the immune system.

To trigger drug release, the team used ultrasound waves at frequencies of 300 or 900 kilohertz, which are beyond human hearing. The ultrasound beam can be precisely directed to target areas within the body that are just a few millimeters in size. It is believed that the ultrasound causes the perfluorocarbons within the nanocarriers to expand, stretching the droplet’s shell and increasing its permeability, allowing the drug to diffuse to the targeted organs, tissues, or cells. The effectiveness of the drug delivery was tested using the anesthetic propofol with different perfluorocarbons: perfluoropentane (PFP), decafluoropentane (DFP), and perfluorooctylbromide (PFOB).

The testing involved delivering ultrasound to the nanodroplets in vitro in 60 pulses of 100 milliseconds each over a minute. The results indicated that PFOB cores offered an optimal balance between droplet stability and delivery efficiency. For safety assessment, the researchers administered six doses of PFOB-based nanodroplets to a long-tailed macaque at weekly intervals, monitoring a series of blood biomarkers to track liver, kidney, and immune function. The study's results, which were published on June 19 in the journal Frontiers in Molecular Biosciences, confirmed that the nanodroplets were well tolerated and did not produce detectable side effects.

“Here we show a method to deliver drugs to specific areas of the body where they are needed. We do so using ultrasound waves, which trigger drug release from circulating nanocarriers when focused on the target,” said Matthew G Wilson, a graduate research assistant at the University of Utah, and the study’s first author. “We developed a method to produce stable nanocarriers repeatably, and identified ultrasound parameters that can activate them.”

Related Links:
University of Utah

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Illuminator
Trimline Basic
New
Mobile Digital X-Ray System
MobileDiagnost wDR 2.1
New
Powered Echocardiography Imaging/Ultrasound Table
Powered Echo

Print article
Radcal

Channels

MRI

view channel
Image: The pathways in the brain highlighted are those most affected by concussion (Photo courtesy of Benjamin Hacker et al)

AI Model Diagnoses Traumatic Brain Injury from MRI Scans With 99% Accuracy

A concussion is a type of traumatic brain injury that may lead to temporary disruptions in brain function. Occurring from incidents such as sports injuries, whiplash, or a simple bump to the head, many... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.